White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of Livmoniplimab and Budigalimab in Patients with Advanced or Metastatic Solid Tumors

Not recruiting

1 1 1
Investigated Diseases:
- Malignant mast cell neoplasm
Investigated Drugs:
- Livmoniplimab
- Budigalimab
Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Not recruiting

3 1 1
Investigated Diseases:
- Thrombotic microangiopathy
Investigated Drugs:
- Ravulizumab
+3
Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease

Not recruiting

3 1 1
Investigated Drugs:
- Empagliflozin
Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Not recruiting

3 1 1 1
Investigated Diseases:
- Haemophilia A without inhibitors
Investigated Drugs:
- Emicizumab
Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Not recruiting

3 1 1
Investigated Drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study on Amantadine Hemisulfate for Patients with Unresponsive Wakefulness Syndrome in Intensive and Intermediate Care Units

Not recruiting

2 1 1 1
Investigated Drugs:
- Amantadine Hemisulfate
Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Not recruiting

2 1
Investigated Drugs:
- Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Not recruiting

3 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
+6
Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Not recruiting

2 1 1 1
Investigated Drugs:
Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Not recruiting

3 1
Investigated Diseases:
- Schizophrenia
Investigated Drugs:
- Valbenazine Ditosylate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies